Research grants in Japan
90 open research grants in Japan. Research funding calls and grants, each from its official source, soonest closing first.
Fiscal Year 2026 Ministry of Defense version of SBIR
Ministry of Defense · Japan
Closes
(Fiscal Year 2026) Medical Device Development Support Research Program (Healthtech Challenge) (1) Research topics aiming to capture the world market with innovative medical devices (especially therapeutic devices) based on unmet medical needs
Japan Agency for Medical Research and Development · Japan
Closes
(Fiscal Year 2026) Medical Device Development Support Research Program (Healthtech Challenge) (2) Research topics on program medical devices (SaMD) using AI technology, aiming for broad adoption in medical institutions and homes
Japan Agency for Medical Research and Development · Japan
Closes
官民による若手研究者発掘支援事業／契約学科型 第2回公募
New Energy and Industrial Technology Development Organization · Japan
Closes
ディープテック・スタートアップ支援基金／科学とビジネスの近接化時代の大規模産学連携拠点形成事業 第2回公募
New Energy and Industrial Technology Development Organization · Japan
Closes
Additional Call for the 2026 Green Innovation Fund Project / Development of Next-Generation Solar Cells / Demonstration Project
New Energy and Industrial Technology Development Organization · Japan
Closes
Drug Discovery and Development Using Platform Technologies for Undruggable Targets
Japan Agency for Medical Research and Development · Japan
Closes
Program for Strengthening the Drug Discovery Venture Ecosystem / Drug Discovery Venture Open Call (15th)
Japan Agency for Medical Research and Development · Japan
Closes
FY2026 call "Bio-bank Utilization Program for Realizing Next-Generation Medicine (Platform for Advancing Next-Generation Medicine, Social Co-creation Domain)"
Japan Agency for Medical Research and Development · Japan
Closes
高頻度打上げに資するロケット部品・コンポーネント等の開発（追加公募）
Japan Aerospace Exploration Agency · Japan
Closes
A-1. Research field on the practical application of innovative drugs for rare and intractable diseases / Seed exploration research on drugs (Drug Step 0)
Japan Agency for Medical Research and Development · Japan
Closes
A-2. Research field on the practical application of innovative drugs for rare and intractable diseases / Seed exploration research on drugs (Drug Step 0, ultra-rare)
Japan Agency for Medical Research and Development · Japan
Closes
A-3. Research field on the practical application of innovative drugs for rare and intractable diseases / Preparation for clinical trials of drugs (Drug Step 1)
Japan Agency for Medical Research and Development · Japan
Closes
A-4. Research field on the practical application of innovative drugs for rare and intractable diseases / Protocol preparation toward clinical trials of drugs (Drug Pre-Step 2)
Japan Agency for Medical Research and Development · Japan
Closes
A-5. Research field on the practical application of innovative drugs for rare and intractable diseases / Clinical trials of drugs (Drug Step 2)
Japan Agency for Medical Research and Development · Japan
Closes
B-1. Research field on the practical application of innovative regenerative, cell-based and gene therapies for rare and intractable diseases / Seed exploration research on regenerative, cell-based and gene therapies (Regenerative medicine Step 0)
Japan Agency for Medical Research and Development · Japan
Closes
B-2. Development Field for Groundbreaking Regenerative, Cellular, and Gene Therapies for Rare and Refractory Diseases / Preparation of Clinical Trials/Clinical Research of Regenerative, Cellular, and Gene Therapies (Step 1)
Japan Agency for Medical Research and Development · Japan
Closes
B-3. Development Field for Groundbreaking Regenerative, Cellular, and Gene Therapies for Rare and Refractory Diseases / Preparation of Clinical Trials/Clinical Research for Regenerative, Cellular, and Gene Therapies Preparatory Products (Pre-Step 2)
Japan Agency for Medical Research and Development · Japan
Closes
B-4. Development Field for Groundbreaking Regenerative, Cellular, and Gene Therapies for Rare and Refractory Diseases / Clinical Trials/Clinical Research of Regenerative, Cellular, and Gene Therapies (Step 2)
Japan Agency for Medical Research and Development · Japan
Closes
C-2. Development Field for Groundbreaking Medical Devices for Rare and Refractory Diseases / Research and Development of Medical Device Program (SaMD)
Japan Agency for Medical Research and Development · Japan
Closes
C-1. Development Field for Groundbreaking Medical Devices for Rare and Refractory Diseases / Seed Exploration of Medical Devices (Device Step 0) (excluding SaMD)
Japan Agency for Medical Research and Development · Japan
Closes
C-3. Development Field for Groundbreaking Medical Devices for Rare and Refractory Diseases / Preparation of Clinical Trials for Medical Devices (Device Step 1)
Japan Agency for Medical Research and Development · Japan
Closes
C-4. Development Field for Groundbreaking Medical Devices for Rare and Refractory Diseases / Clinical Trials of Medical Devices (Device Step 2)
Japan Agency for Medical Research and Development · Japan
Closes
D-1. Evidence Generation Directly Relating to Clinical Practice / Evidence Generation for Rare and Refractory Diseases (Evidence Generation)
Japan Agency for Medical Research and Development · Japan
Closes
D-5. Evidence Generation Directly Relating to Clinical Practice / Evidence Generation for Nutrition Management in Rare and Refractory Diseases (Nutrition)
Japan Agency for Medical Research and Development · Japan
Closes
F-4. Rare and Refractory Disease Mechanism Elucidation Field / Verification of Drug Targets Identified by Young Researchers’ Rare and Refractory Disease Mechanism Elucidation (Mechanism Elucidation / Youth / Research Y1)
Japan Agency for Medical Research and Development · Japan
Closes
F-1. Rare and Refractory Disease Mechanism Elucidation Field / Rare and Refractory Disease Mechanism Elucidation Targeted at Identifying Drug Targets (Mechanism Elucidation / Research 0)
Japan Agency for Medical Research and Development · Japan
Closes
D-2. Evidence Generation Directly Relating to Clinical Practice / Evidence Generation for Pediatric Onset Rare and Refractory Diseases (Pediatrics)
Japan Agency for Medical Research and Development · Japan
Closes
D-3. Evidence Generation Directly Relating to Clinical Practice / Evidence Generation for Ultra-Rare Refractory Diseases (Ultra-Rare)
Japan Agency for Medical Research and Development · Japan
Closes
D-4. Evidence Generation Directly Relating to Clinical Practice / Evidence Generation Using Real-World Data for Rare and Refractory Diseases (RWD)
Japan Agency for Medical Research and Development · Japan
Closes
pitute matches every opening to your field and watches for new ones for you. Join pitute to see the ones that fit you first.